WeVote

Bill

Bill

SB 668

State pharmacy benefits manager; contractual provisions, report.

2026 Regular Session Introduced by Aaron Rouse

SB 668 establishes contractual requirements and reporting standards for Virginia state pharmacy benefits managers to increase transparency and potentially reduce prescription drug costs.

Fiscal Impact Statement from Department of Planning and Budget (SB668)
0
WeVote Research Nonpartisan
Bill Summary · SB 668

Legislative bill overview

SB 668 regulates contractual provisions and operational requirements for pharmacy benefits managers (PBMs) operating in Virginia, particularly those managing state health benefit plans. The bill requires PBMs to comply with specific contractual standards and mandates reporting to state authorities on their practices and pricing structures.

Why is this important

PBMs act as intermediaries between insurers, pharmacies, and patients, controlling drug pricing and access—making their practices significantly impact medication costs and availability for Virginia residents. Increased transparency and contractual requirements could lower drug costs for state employees and beneficiaries, though compliance costs may be passed to consumers. This reflects a national trend of states attempting to regulate PBM practices after federal scrutiny over their role in rising prescription drug prices.

Potential points of contention

  • Industry compliance costs: PBMs may argue that regulatory requirements and reporting mandates increase operational costs, potentially raising premiums for state plan participants
  • Federal vs. state authority: Questions about whether state-level PBM regulation conflicts with federal oversight of pharmacy benefit arrangements and ERISA-regulated plans
  • Competitive impact: Requirements could disadvantage smaller PBMs or reduce market competition if compliance barriers are prohibitively expensive for new entrants

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.